The Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) is a group of 10 universities and childrens hospitals, that came together to offer a national network of clinical trials based on the research derived from a group of closely collaborating investigators, who are linked with laboratory programs developing novel therapies for high-risk neuroblastoma and medulloblastoma.
Please contact us for more information.
Clinical Trials See which trials are open and where. |
Participating Hospitals Maps and contact information for the hospitals offering NMTRC trials. |
Scientific TeamLearn more about the people behind the NMTRC. |